Point-of-care testing strategy versus usual care to safely reduce antibiotic prescribing for acute respiratory tract infections in primary care (PRUDENCE): a pragmatic, randomised controlled trial in 13 countries

  20 March 2026

The PRUDENCE trial evaluated whether point-of-care (POC) testing (including CRP, strep A, and influenza tests) could reduce antibiotic prescribing for respiratory tract infections in primary care across 13 countries.

In over 2,600 patients, POC testing did not significantly reduce antibiotic use compared to usual care (45.7% vs 47.1%). Importantly, patient recovery was similar in both groups, with a median of 4 days to return to normal activities, confirming that POC testing is safe but not more effective in this context.

The key takeaway: when clinicians are already inclined to prescribe antibiotics, diagnostic testing alone does not change prescribing behavior. Therefore, POC testing is unlikely to be effective as a standalone antimicrobial stewardship strategy and should be combined with behavioural, educational, and system-level interventions.

Further reading: The Lancet Primary Care
Author(s): Alike W van der Velden et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!